PEP-Therapy receives FDA Orphan Drug Designation for - GlobeNewswire

Retrieved on: 2025-03-17 13:07:18

Tags for this article:

Click the tags to see associated articles and topics

PEP-Therapy receives FDA Orphan Drug Designation for - GlobeNewswire. View article details on hiswai:

Excerpt

Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in ...

Article found on: www.globenewswire.com